Benjamin Gaddie, OD, FAAO

Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.

Aiming to address long-standing challenges without sacrificing accuracy.

Ben Gaddie, OD, FAAO closes this series discussing his treatment protocol for patients with demodex blepharitis, reflecting on the major treatment advancements that can quickly alleviate patient symptoms.

Ben Gaddie, OD, FAAO presents the second patient case of a 66-year-old white female with eye dryness and irritation. Though she was not previously treated for demodex blepharitis, he demonstrates how it was the root cause of many symptoms she experienced.

Ben Gaddie, OD, FAAO discusses demodex blepharitis, common symptoms, and prior treatment options that struggled to control their reproductive cycle.

Ben Gaddie, OD, FAAO presents the first patient case of a 53-year-old white female who has tried many treatments. Gaddie highlights his treatment approach and how the patient saw improvements within eight weeks.

New technology may be able to help ODs’ most challenging patient segment

Study shows improved OBF throughout the retina with antioxidant supplementation